WP
BIS icon

WealthSource Partners’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

WealthSource Partners’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,025
Closed -$362K – 468
2021
Q1 		$362K Sell
8,025
-1,000
-11% -$42K 0.04% 307
2020
Q4 		$425K Sell
9,025
-500
-5% -$27.3K 0.05% 233
2020
Q3 		$590K Buy
9,525
+900
+10% +$57.5K 0.08% 166
2020
Q2 		$555K Buy
8,625
+6,750
+360% +$525K 0.08% 173
2020
Q1 		$212K Sell
1,875
-8,500
-82% -$971K 0.03% 297
2019
Q4 		$1.11M Buy
10,375
+4,000
+63% +$515K 0.15% 128
2019
Q3 		$1.02M Sell
6,375
-2,563
-29% -$376K 0.15% 138
2019
Q2 		$1.22M Sell
8,938
-1,812
-17% -$265K 0.19% 120
2019
Q1 		$1.44M Buy
+10,750
New +$1.52M 0.32% 75
2018
Q4 		– Sell
-8,363
Closed -$1.05M – 305
2018
Q3 		$1.05M Buy
8,363
+1,250
+18% +$168K 0.27% 81
2018
Q2 		$1.11M Buy
7,113
+113
+2% +$18.8K 0.31% 81
2018
Q1 		$1.18M Buy
7,000
+3,062
+78% +$492K 0.36% 68
2017
Q4 		$695K Buy
+3,938
New +$699K 0.22% 107

Other funds holding BIS

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

WealthSource Partners's BIS Position: Q2 2021 in Review

WealthSource Partners sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q2 2021, closing a stake of 8,025 shares — an estimated $362K sold.

WealthSource Partners first reported a position in BIS in Q4 2017 and held it in 13 quarters. The position peaked at $1.44M in Q1 2019. 7 funds tracked by Wall St. Rank hold BIS as of Q2 2021.

  • WealthSource Partners reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q2 2021 after selling out during the quarter.
  • WealthSource Partners sold 8,025 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2021, an estimated $362K.
  • WealthSource Partners first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q4 2017 and held it in 13 quarters.
  • WealthSource Partners's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.44M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2021.

Based on WealthSource Partners's 13F filing for Q2 2021, filed 18 Nov 2021.